Samsung Biologics
Samsung Biologics is a leading CDMO, offering integrated services that range from late discovery to commercial manufacturing. With 785,000 liters of capacity in Korea and 60,000 liters in Rockville, Maryland, U.S., the company supports diverse modalities, including multispecific antibodies, antibody-drug conjugates, and mRNA therapeutics, by leveraging its advanced technologies and expertise to deliver safe, high-quality biomedicines to patients worldwide.
